Plerixafor is highly effective in the mobilisation of PBSC for autologous transplantation from patients failing to mobilise by conventional means: the initial Scottish experience in three transplant centres

The small molecule chemokine inhibitor Plerixafor has recently been used on a named-patient basis for PBSC mobilisation from patients failing to mobilise by conventional means. We present our initial experience with plerixafor in 18 mobilisation attempts in 17 patients, all of whom had previously fa...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	Bone marrow transplantation (Basingstoke) 2009-03, Vol.43 (S1), p.S113
Hauptverfasser:	Gordon, W.C, Johnson, P.R.E, Roddie, P.H, Shepherd, P.C.A, Scott, Shepherd, Davies, J.M, Manson, L.M, Culligan, D, Chee, Y.-L, Parker, A, McQuaker, I.G, Clark, A, Soutar, R.L, Douglas, K.W
Format:	Artikel
Sprache:	eng
Schlagworte:	Care and treatment Hematopoietic stem cells Lymphomas Transplantation
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!